Fasenra

Astrazeneca's Fasenra Gets Orphan Drug Designation for Autoimmune Disease
Astrazeneca's Fasenra Gets Orphan Drug Designation for Autoimmune Disease
Yahoo/Zacks.com
AstraZeneca
Fasenra
orphan drugs
FDA
eosinophilic granulomatosis with polyangiitis
Flag link:
AstraZeneca, shut out of COPD, touts long-term Fasenra asthma data
AstraZeneca, shut out of COPD, touts long-term Fasenra asthma data
Fierce Pharma
AstraZeneca
COPD
Fasenra
asthma
Flag link:
NICE says yes to AstraZeneca’s Fasenra, but only when its GSK rival can’t be used
NICE says yes to AstraZeneca’s Fasenra, but only when its GSK rival can’t be used
Fierce Pharma
AstraZeneca
Fasenra
GSK
Nucala
NICE
asthma
Flag link:
AstraZeneca drug Fasenra fails to achieve main goal in COPD trial
AstraZeneca drug Fasenra fails to achieve main goal in COPD trial
Yahoo/Reuters
AstraZeneca
Fasenra
COPD
clinical trials
Flag link:
AstraZeneca's Fasenra (benralizumab) Fails Ph III Trial for COPD
AstraZeneca's Fasenra (benralizumab) Fails Ph III Trial for COPD
CP Wire
AstraZeneca
MedImmune
Fasenra
COPD
Flag link:
AstraZeneca's Fasenra (benralizumab) Fails Ph III Trial for COPD
AstraZeneca
Fasenra
COPD
Flag link:
Drugmakers take to Japan: 3 new drug approvals won by AstraZeneca, Merck, and EA Pharma
Drugmakers take to Japan: 3 new drug approvals won by AstraZeneca, Merck, and EA Pharma
Endpoints
AstraZeneca
Lynparza
Merck
ovarian cancer
asthma
Japan
Fasenra
EA Pharma
elobixibat
Flag link:
GlaxoSmithKline's Nucala, buoyed by its medical organization, ready to 'fiercely compete' with AstraZeneca
GlaxoSmithKline's Nucala, buoyed by its medical organization, ready to 'fiercely compete' with AstraZeneca
Fierce Pharma
GSK
Nucala
AstraZeneca
Fasenra
eosinophilic asthma
asthma
Flag link: